New Cryptocurrency Looking to Appeal to the Masses
Divi Coins wants to make their cryptocurrency as convenient and accessible as possible. The Divi Project is a new crypto company that closed their initial coin sale in November. The new crypto is looking to replace exchanges like Paypal or Venmo.
Geoff McCabe is the Co-founder and CEO at The Divi Project Tim Sanders is the CMO at The Divi Project. The pair joined Cheddar to explain why they think their new cryptocurrency will lead the market. Sanders stresses that as a company, Divi is attentive and responsive to their consumers' needs.
McCabe believes that in the future all cryptocurrencies will be interchangeable and exchanged via digital wallets. So for Divi, the key is to be adopted and trusted by as many people as possible. In terms of future steps, The Divi Project is looking to build out their own blockchain and wallet.
On Monday, football fans were stunned when Buffalo Bills safety Damar Hamlin collapsed and suffered cardiac arrest. Cheddar News explains the condition and the steps to take if you witness an incident.
What's being called an unprecedented breakthrough in cancer treatment recently completed a small trial at New York City's Memorial Sloan Kettering in 14 rectal cancer patients. The experimental trial with the drug dostarlimab resulted in 100 percent remission in all candidates, precluding the need for chemotherapy or surgery. Cheddar News anchor Hena Doba dives into this hopeful story.
Join Cheddar News as we break down the top headlines this morning including updates on the Jan. 6 hears, the PGA suspension of 17 of the world's best golfers, and NASA's plans to study UFOs.
Rick Pauls, President & CEO OF DiaMedica Therapeutics, joins Cheddar Innovates to discuss a new ischemic stroke treatment option that expands the window for effective therapy for stroke patients.
John Bencich, CEO of Achieve Life Sciences, joins Cheddar Innovates to discuss a new plant-based compound that's being used to fight nicotine addiction.
On this episode of Cheddar Innovates: CEO of Achieve Life Sciences discusses a new plant-based compound that's being used to fight nicotine addiction; President & CEO OF DiaMedica Therapeutics explains a new ischemic stroke treatment option that expands the window for effective therapy for stroke patients; Cheddar gets a look at Curiosity Stream's 'Asteroid Rush.'